Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CUARTET: ctDNA in Japanese mCSPC Patients Receiving Apalutamide
jRCTs071200040Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of apalutamide in prostate cancer (PCa), sponsored by Janssen Pharmaceutical. Started Nov 2020; status: completed.
02
Drugs
apalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on jRCTs071200040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071200040.